HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MEDTIDE

22.900

-0.100-0.43%

Volume:50.70K

Turnover:1.17M

Market Cap:3.25B

PE:53.35

High:23.380

Open:23.000

Low:22.560

Close:23.000

52wk High:41.720

52wk Low:21.500

Shares:141.80M

HK Float Shares:141.80M

Volume Ratio:1.38

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.429

ROE:12.46%

ROA:6.53%

PB:1.94

PE(LYR):53.35

PS:5.72

Loading ...

Overview Company News Filings

Medtide Inc. (03880) Sets 30 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal

Bulletin Express

Medtide Inc. schedules board meeting to approve annual results and consider final dividend

Pangea Wellness to Rename as The Precision Peptide Company on March 18, 2026

Medtide Completes Hong Kong-Listed Share Full Circulation

MT Newswires Live

MEDTIDE Completes Conversion of Domestic Shares to H Shares

MEDTIDE (03880.HK) Completes H-Share Full Circulation; 68.20 Million Domestic Shares Converted, Free Float Rises to 100%

Bulletin Express

MEDTIDE (03880) Announces February 2026 Monthly Return with No Change in Share Capital

Bulletin Express

MEDTIDE's Annual Profit Surge Fails to Impress Amid 50% Stock Plunge

BRIEF-Medtide Sees Revenue For Year Within Range Of Rmb555 Million To Rmb585 Million

Medtide Inc. (Stock Code: 3880) Announces Positive Profit Alert

Bulletin Express

MEDTIDE Issues Profit Alert, Forecasts Adjusted Net Profit Between RMB200 Million and RMB230 Million for Fiscal Year

Medtide Inc Sees Revenue for Year Within Range of RMB555 Millio to RMB585 Mln

THOMSON REUTERS

Medtide forecasts 2025 profit of RMB200 million to RMB230 million

Medtide Inc. (3880) Receives CSRC Filing Notice for H Share Full Circulation

Bulletin Express

MEDTIDE Receives CSRC Filing Notice for H-Share Full Circulation Plan

CSRC erteilt Medtide Inc. eine Filing Notice für H-Aktien-Umlaufantrag

Medtide Inc. (HKG:3880) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Simply Wall St.

MEDTIDE (03880) Notches Eight Consecutive Gains Ahead of Lock-up Expiry: A Bid to Reclaim IPO Price?

Medtide Inc. (03880) Announces Monthly Return on Movements in Securities for November 2025

Bulletin Express

Medtide Inc.'s (HKG:3880) last week's 9.3% decline must have disappointed retail investors who have a significant stake

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/03880/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"03880","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","market":"HK","secType":"STK","nameCN":"MEDTIDE","latestPrice":22.9,"timestamp":1773804150564,"preClose":23,"halted":0,"volume":50700,"delay":0,"changeRate":-0.004347826086956583,"floatShares":141800000,"shares":141800000,"eps":0.429249207810124,"marketStatus":"Trading","change":-0.1,"latestTime":"03-18 11:26:09","open":23,"high":23.38,"low":22.56,"amount":1165076,"amplitude":0.035652,"askPrice":22.92,"askSize":800,"bidPrice":22.64,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":0.9739767436391854,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1773806400000},"marketStatusCode":2,"adr":0,"listingDate":1751212800000,"exchange":"SEHK","adjPreClose":23,"openAndCloseTimeList":[[1773797400000,1773806400000],[1773810000000,1773820800000]],"volumeRatio":1.380309,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","floatShares":141800000,"roa":"6.53%","roe":"12.46%","lyrEps":0.429249,"volumeRatio":1.380309,"shares":141800000,"dividePrice":0,"high":23.38,"amplitude":0.035652,"preClose":23,"low":22.56,"week52Low":21.5,"pbRate":"1.94","psRate":"5.72","week52High":41.72,"institutionHeld":0,"latestPrice":22.9,"committee":0.428571,"eps":0.429249207810124,"divideRate":0,"volume":50700,"delay":0,"ttmEps":0.9739767436391854,"open":23,"prevYearClose":30.48,"prevWeekClose":22.86,"prevMonthClose":25.62,"prevQuarterClose":30.48,"fiveDayClose":22.8,"twentyDayClose":26.3,"sixtyDayClose":28.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03880\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03880\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03880\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1754409600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03880\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03880","date":"2026-03-17","current":23.975108,"percent":0.039548,"low":25.082632,"twenty":31.835165,"median":35.946562,"eighty":73.330469,"high":89.502411,"avg":44.603405,"sd":19.250965,"marketCap":3261400000},"quantilePoints":[{"date":"2025-06-27","current":64.550519,"twenty":64.550519,"median":64.550519,"eighty":64.550519,"marketCap":4183100000},{"date":"2025-07-04","current":69.032987,"twenty":66.795355,"median":68.595377,"eighty":69.313609,"marketCap":4473790000},{"date":"2025-07-11","current":68.445519,"twenty":67.311524,"median":68.276633,"eighty":68.994281,"marketCap":4431250000},{"date":"2025-07-18","current":76.171108,"twenty":67.389311,"median":68.984604,"eighty":75.214843,"marketCap":4927550000},{"date":"2025-07-25","current":74.03868,"twenty":67.965697,"median":71.906475,"eighty":74.616858,"marketCap":4807020000},{"date":"2025-08-01","current":77.026259,"twenty":68.377965,"median":73.828208,"eighty":76.342138,"marketCap":4970090000},{"date":"2025-08-08","current":73.611635,"twenty":68.565405,"median":73.719922,"eighty":75.214843,"marketCap":4761644000},{"date":"2025-08-15","current":78.991101,"twenty":68.906759,"median":73.83709,"eighty":76.342138,"marketCap":5101964000},{"date":"2025-08-22","current":89.502411,"twenty":69.02331,"median":74.090002,"eighty":78.320217,"marketCap":5762752000},{"date":"2025-08-29","current":78.512395,"twenty":70.155476,"median":74.257083,"eighty":79.74991,"marketCap":5079276000},{"date":"2025-09-05","current":41.646228,"twenty":68.906759,"median":74.188856,"eighty":79.74991,"marketCap":5031064000},{"date":"2025-09-12","current":37.986037,"twenty":67.389311,"median":74.066692,"eighty":79.087699,"marketCap":4597156000},{"date":"2025-09-19","current":35.879032,"twenty":42.439428,"median":73.832649,"eighty":78.741923,"marketCap":4339080000},{"date":"2025-09-26","current":35.972365,"twenty":39.207677,"median":73.603619,"eighty":78.545842,"marketCap":4339080000},{"date":"2025-10-03","current":36.895298,"twenty":38.254613,"median":73.439791,"eighty":78.477782,"marketCap":4461028000},{"date":"2025-10-10","current":35.939087,"twenty":37.926552,"median":73.260895,"eighty":78.387462,"marketCap":4339080000},{"date":"2025-10-17","current":35.261849,"twenty":36.980504,"median":69.008796,"eighty":78.069934,"marketCap":4254000000},{"date":"2025-10-24","current":35.954012,"twenty":36.188249,"median":68.445519,"eighty":77.701013,"marketCap":4339080000},{"date":"2025-10-31","current":35.900465,"twenty":36.021695,"median":67.397498,"eighty":77.513348,"marketCap":4339080000},{"date":"2025-11-07","current":35.922904,"twenty":35.979492,"median":65.840942,"eighty":76.855229,"marketCap":4339080000},{"date":"2025-11-14","current":36.196001,"twenty":35.973277,"median":41.646228,"eighty":76.009632,"marketCap":4384456000},{"date":"2025-11-21","current":32.839875,"twenty":35.967307,"median":40.069862,"eighty":75.286139,"marketCap":3976072000},{"date":"2025-11-28","current":33.374508,"twenty":35.955467,"median":38.580928,"eighty":74.943808,"marketCap":4055480000},{"date":"2025-12-05","current":32.851251,"twenty":35.944759,"median":38.254067,"eighty":74.758171,"marketCap":3998760000},{"date":"2025-12-12","current":33.023157,"twenty":35.900465,"median":37.886895,"eighty":74.473119,"marketCap":4027120000},{"date":"2025-12-19","current":34.430381,"twenty":35.39442,"median":37.394857,"eighty":74.229792,"marketCap":4208624000},{"date":"2025-12-24","current":34.99421,"twenty":35.141853,"median":37.085683,"eighty":74.147921,"marketCap":4290868000},{"date":"2026-01-02","current":33.635992,"twenty":35.029056,"median":36.743987,"eighty":74.11624,"marketCap":4140560000},{"date":"2026-01-09","current":32.725127,"twenty":34.456149,"median":36.454304,"eighty":74.08534,"marketCap":4038464000},{"date":"2026-01-16","current":32.687847,"twenty":33.647972,"median":36.236629,"eighty":74.049885,"marketCap":4046972000},{"date":"2026-01-23","current":31.091299,"twenty":33.318703,"median":36.073206,"eighty":73.917726,"marketCap":3845616000},{"date":"2026-01-30","current":31.269354,"twenty":33.177249,"median":36.016394,"eighty":73.831761,"marketCap":3885320000},{"date":"2026-02-06","current":27.433753,"twenty":32.966335,"median":35.983345,"eighty":73.698264,"marketCap":3417380000},{"date":"2026-02-13","current":29.767101,"twenty":32.846701,"median":35.969241,"eighty":73.606825,"marketCap":3729340000},{"date":"2026-02-20","current":29.696692,"twenty":32.725127,"median":35.967659,"eighty":73.603619,"marketCap":3715160000},{"date":"2026-02-27","current":28.724265,"twenty":32.439619,"median":35.961022,"eighty":73.603001,"marketCap":3632916000},{"date":"2026-03-06","current":25.544273,"twenty":32.105235,"median":35.955322,"eighty":73.439791,"marketCap":3204680000},{"date":"2026-03-13","current":25.719686,"twenty":31.941403,"median":35.950844,"eighty":73.376851,"marketCap":3241548000},{"date":"2026-03-17","current":25.913162,"twenty":31.835165,"median":35.946562,"eighty":73.330469,"marketCap":3261400000}],"updateTime":1773798470397},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03880\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1153266924","title":"Medtide Inc. (03880) Sets 30 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=1153266924","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153266924?lang=en_us&edition=fundamental","pubTime":"2026-03-16 23:01","pubTimestamp":1773673303,"startTime":"0","endTime":"0","summary":"Medtide Inc. (Stock Code: 03880) has scheduled a board meeting for Monday, 30 March 2026. According to the announcement released on 16 March 2026, the agenda includes: • Reviewing and approving the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"2619464526","title":"Medtide Inc. schedules board meeting to approve annual results and consider final dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2619464526","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619464526?lang=en_us&edition=fundamental","pubTime":"2026-03-16 22:48","pubTimestamp":1773672499,"startTime":"0","endTime":"0","summary":"Medtide will hold a board meeting on March 30, 2026 to consider and approve its annual results for the year ended December 31, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL1SWGJW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"gpt_icon":0},{"id":"2619194292","title":"Pangea Wellness to Rename as The Precision Peptide Company on March 18, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2619194292","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619194292?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:08","pubTimestamp":1773403731,"startTime":"0","endTime":"0","summary":"Pangea said it will change its name to The Precision Peptide Company. The company said its shares are expected to trade on the CSE under the symbol BPC. Pangea also reported a new CUSIP of 74031F104 and a new ISIN of CA74031F1045.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL9ZBhXY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"gpt_icon":0},{"id":"2618662443","title":"Medtide Completes Hong Kong-Listed Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2618662443","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618662443?lang=en_us&edition=fundamental","pubTime":"2026-03-09 22:05","pubTimestamp":1773065152,"startTime":"0","endTime":"0","summary":"Medtide (HKG:3880) completed the conversion of 68.2 million unlisted shares into Hong Kong-listed shares on Monday, according to a same-day Hong Kong bourse filing.The listing of the peptide-focused CRDMO's converted shares on the Hong Kong stock exchange will begin at 9:00 am on March 10.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["03880","BK1141"],"gpt_icon":0},{"id":"1145434260","title":"MEDTIDE Completes Conversion of Domestic Shares to H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1145434260","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145434260?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:10","pubTimestamp":1773058229,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) has announced the successful conversion of 68.2011 million non-tradable shares into H shares, which was finalized on March 9, 2026. The converted H shares are scheduled to commence trading on the Stock Exchange of Hong Kong starting at 9:00 a.m. on March 10, 2026.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"gpt_icon":0},{"id":"1132041759","title":"MEDTIDE (03880.HK) Completes H-Share Full Circulation; 68.20 Million Domestic Shares Converted, Free Float Rises to 100%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132041759","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132041759?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:03","pubTimestamp":1773057798,"startTime":"0","endTime":"0","summary":"Medtide Inc. (stock code: 03880.HK) announced the completion of its H-share full-circulation programme, converting 68.20 million previously unlisted domestic shares into H shares. Trading in the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"1162073233","title":"MEDTIDE (03880) Announces February 2026 Monthly Return with No Change in Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1162073233","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162073233?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:22","pubTimestamp":1772616156,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) disclosed its February 2026 monthly return, confirming that the company’s total issued share capital remained at 141.80 million shares. Of these, 73.60 million are H shares and 68.20...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"1160058425","title":"MEDTIDE's Annual Profit Surge Fails to Impress Amid 50% Stock Plunge","url":"https://stock-news.laohu8.com/highlight/detail?id=1160058425","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160058425?lang=en_us&edition=fundamental","pubTime":"2026-02-28 16:01","pubTimestamp":1772265682,"startTime":"0","endTime":"0","summary":"On February 26, before market opening, MEDTIDE (03880) issued a profit alert for the 2025 fiscal year. According to the announcement, the company anticipates revenue to be between 555 million and 585...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"gpt_icon":0},{"id":"2614698960","title":"BRIEF-Medtide Sees Revenue For Year Within Range Of Rmb555 Million To Rmb585 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614698960","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614698960?lang=en_us&edition=fundamental","pubTime":"2026-02-26 09:20","pubTimestamp":1772068853,"startTime":"0","endTime":"0","summary":"BRIEF-Medtide Sees Revenue For Year Within Range Of Rmb555 Million To Rmb585 MillionFeb 26  - Medtide Inc 3880.HK:SEES  REVENUE FOR YEAR WITHIN RANGE OF RMB555 MILLIO TO RMB585 MILLIONSEES  PROFIT FOR YEAR  WITHIN RANGE OF RMB200 MILLION TO RMB230 MILLIONFurther company coverage: 3880.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nFWN3ZL28N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"gpt_icon":0},{"id":"1162146850","title":"Medtide Inc. (Stock Code: 3880) Announces Positive Profit Alert","url":"https://stock-news.laohu8.com/highlight/detail?id=1162146850","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162146850?lang=en_us&edition=fundamental","pubTime":"2026-02-26 08:21","pubTimestamp":1772065266,"startTime":"0","endTime":"0","summary":"Medtide Inc. (泰德醫藥 (浙江) 股份有限公司) (Stock Code: 3880) announced that revenue for the year ended December 31, 2025 is expected to reach RMB555.00 million to RMB585.00 million, representing a year-on-year...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"1188288091","title":"MEDTIDE Issues Profit Alert, Forecasts Adjusted Net Profit Between RMB200 Million and RMB230 Million for Fiscal Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1188288091","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188288091?lang=en_us&edition=fundamental","pubTime":"2026-02-26 08:20","pubTimestamp":1772065227,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) has announced an optimistic profit forecast. The group anticipates revenue for the fiscal year ending December 31, 2025, to be approximately RMB555 million to RMB585 million. This...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"gpt_icon":0},{"id":"2614063825","title":"Medtide Inc  Sees  Revenue for Year Within Range of RMB555 Millio to RMB585 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2614063825","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614063825?lang=en_us&edition=fundamental","pubTime":"2026-02-26 08:01","pubTimestamp":1772064066,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nFWN3ZL28N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03880","BK1141"],"gpt_icon":0},{"id":"2614063829","title":"Medtide forecasts 2025 profit of RMB200 million to RMB230 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614063829","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614063829?lang=en_us&edition=fundamental","pubTime":"2026-02-26 08:01","pubTimestamp":1772064061,"startTime":"0","endTime":"0","summary":"Medtide Inc. issued a positive profit alert, expecting 2025 revenue of about RMB555 million to RMB585 million, up roughly 25.5% to 32.3% from RMB442.2 million in 2024. The company forecast 2025 profit of around RMB200 million to RMB230 million, a surge of about 237.8% to 288.5% versus RMB59.2 million a year earlier. Adjusted net profit is also expected at RMB200 million to RMB230 million, up about 16.3% to 33.7% from RMB172.0 million in 2024.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 26, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDLcbybyy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"gpt_icon":0},{"id":"1141129814","title":"Medtide Inc. (3880) Receives CSRC Filing Notice for H Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=1141129814","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141129814?lang=en_us&edition=fundamental","pubTime":"2026-02-05 20:05","pubTimestamp":1770293122,"startTime":"0","endTime":"0","summary":"Medtide Inc. announced that, following the acceptance of its H Share Full Circulation application by the China Securities Regulatory Commission (CSRC) on July 27, 2025, a filing notice was issued on...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"1199551549","title":"MEDTIDE Receives CSRC Filing Notice for H-Share Full Circulation Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1199551549","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199551549?lang=en_us&edition=fundamental","pubTime":"2026-02-05 19:54","pubTimestamp":1770292454,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) has announced that on February 5, 2026, the company received a filing notice from the China Securities Regulatory Commission (CSRC) regarding the conversion and listing of its shares....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"gpt_icon":0},{"id":"2609085371","title":"CSRC erteilt Medtide Inc. eine Filing Notice für H-Aktien-Umlaufantrag","url":"https://stock-news.laohu8.com/highlight/detail?id=2609085371","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609085371?lang=en_us&edition=fundamental","pubTime":"2026-02-05 19:49","pubTimestamp":1770292194,"startTime":"0","endTime":"0","summary":"Medtide Inc. hat am 5. Februar 2026 eine Mitteilung der China Securities Regulatory Commission  über den Abschluss der behrdlichen berprüfung im Zusammenhang mit dem Antrag auf vollstndige Umwandlung der H-Aktien des Unternehmens erhalten. Die Umwandlung und Brsennotierung unterliegen weiteren erforderlichen Verfahren durch die CSRC, die Hongkonger Brse sowie andere zustndige in- und auslndische Aufsichtsbehrden.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL47BMPM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"gpt_icon":0},{"id":"2609234686","title":"Medtide Inc. (HKG:3880) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?","url":"https://stock-news.laohu8.com/highlight/detail?id=2609234686","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609234686?lang=en_us&edition=fundamental","pubTime":"2026-02-05 09:10","pubTimestamp":1770253835,"startTime":"0","endTime":"0","summary":"It is hard to get excited after looking at Medtide's (HKG:3880) recent performance, when its stock has declined 19...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3880/medtide-shares/news/medtide-inc-hkg3880-stocks-been-sliding-but-fundamentals-loo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3880/medtide-shares/news/medtide-inc-hkg3880-stocks-been-sliding-but-fundamentals-loo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1141","03880"],"gpt_icon":0},{"id":"1101726428","title":"MEDTIDE (03880) Notches Eight Consecutive Gains Ahead of Lock-up Expiry: A Bid to Reclaim IPO Price?","url":"https://stock-news.laohu8.com/highlight/detail?id=1101726428","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101726428?lang=en_us&edition=fundamental","pubTime":"2025-12-26 11:19","pubTimestamp":1766719153,"startTime":"0","endTime":"0","summary":"On December 30, MEDTIDE (03880) is set to face the expiration of its cornerstone investor lock-up period. Prior to this, the company's stock had endured a three-month downtrend, hitting a new low...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"gpt_icon":0},{"id":"1136210832","title":"Medtide Inc. (03880) Announces Monthly Return on Movements in Securities for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1136210832","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136210832?lang=en_us&edition=fundamental","pubTime":"2025-12-03 17:06","pubTimestamp":1764752802,"startTime":"0","endTime":"0","summary":"Medtide Inc. (stock code: 03880) issued a monthly return on movements in securities for the month ended 30 November 2025. The total issued share capital remains at RMB 141,800,000, comprising...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"gpt_icon":0},{"id":"2585780961","title":"Medtide Inc.'s (HKG:3880) last week's 9.3% decline must have disappointed retail investors who have a significant stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2585780961","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585780961?lang=en_us&edition=fundamental","pubTime":"2025-11-22 06:42","pubTimestamp":1763764950,"startTime":"0","endTime":"0","summary":"Key Insights The considerable ownership by retail investors in Medtide indicates that they collectively have a greater...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3880/medtide-shares/news/medtide-incs-hkg3880-last-weeks-93-decline-must-have-disappo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3880/medtide-shares/news/medtide-incs-hkg3880-last-weeks-93-decline-must-have-disappo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1141","03880"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}]}}